All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10295093" target="_blank" >RIV/00216208:11110/15:10295093 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/15:10295093

  • Result on the web

    <a href="http://dx.doi.org/10.1093/ndt/gfu328" target="_blank" >http://dx.doi.org/10.1093/ndt/gfu328</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1093/ndt/gfu328" target="_blank" >10.1093/ndt/gfu328</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis

  • Original language description

    Despite major advances in the management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) achieved in the last decades, a large proportion of AAV patients still develop end-stage renal disease. The survival of AAV patients dependent on dialysis is significantly worse compared with dialysis-independent AAV patients, but is comparable to other non-diabetic patients requiring dialysis. Renal transplantation (RTx) is the method of choice among renal replacement therapies and there has been increasing evidence that it is a suitable method with favorable patient- and graft-survival also in AAV patients. It is recommended to perform RTx after a parts per thousand yen12 months of remission, and ANCA positivity at the time of RTx isgenerally not considered a contraindication. Even though the risk of relapse after RTx is relatively low with current post-transplant immunosuppressive regimens, disease recurrence may occur. Besides cyclophosphamide, rituximab might beco

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Nephrology Dialysis Transplantation

  • ISSN

    0931-0509

  • e-ISSN

  • Volume of the periodical

    30

  • Issue of the periodical within the volume

    Supplement 1

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    5

  • Pages from-to

    "i159"-"i163"

  • UT code for WoS article

    000353500300023

  • EID of the result in the Scopus database

    2-s2.0-84926640643